
    
      This study is purposed to measure "real world" acute procedural outcomes (procedural
      efficiency and acute safety) associated with use of the CARTOÂ® 3 System and real time
      intracardiac ultrasound in a clinical setting in subjects with drug refractory recurrent
      symptomatic paroxysmal AF.
    
  